The shape of a market decision begins here
We build evidence around the commercial questions that keep healthcare executives focused. Early-stage assessment, message optimization, life-cycle strategy.
The answer is rarely in the data alone.
Most research firms deliver charts. We deliver commercial judgment — built on deep therapeutic knowledge, honest methodology, and a willingness to say what the numbers don't.
What does experience actually look like?
These numbers reflect the depth of commercial challenges we've tackled across therapeutic categories and global markets.
50+
From oncology to rare diseases, we bring category-specific insight to every engagement.
20+
Our team understands commercial dynamics across the U.S., Europe, and emerging regions.
500+
Each one a strategic partnership, not a transactional deliverable.
15+
Primary research, advanced analytics, and real-world evidence built into every project.
Over 200 engagements that shaped decisions
Our clients come back because the work holds up. Here is how they describe working with us.
Healogix brought the therapeutic depth we needed to move our early-stage asset through a complex market landscape. Their analysis gave us clarity we couldn't find elsewhere.
Sarah Chen
VP of Commercial Strategy, Biopharma
We needed a partner who could handle the nuance of global pricing and market access. Healogix delivered a framework that actually worked across regions.
James Atwood
Senior Director, Global Market Access
The message optimization work they did was precise. It cut through our internal noise and gave us a clear path to launch. That kind of strategic rigor is rare.
Priya Nair
Head of Brand Strategy, Specialty Pharma
We have worked with many research firms. Healogix stands apart because they understand the commercial reality behind the data. Their recommendations are grounded.
Michael Torres
Chief Commercial Officer, MedTech
Research designed for the decisions you face
We build custom market research programs that match the specific phase of your product's life cycle, not one-size-fits-all approaches.
Early-stage opportunity assessment
We evaluate market potential and therapeutic landscape before you commit significant resources.
Message optimization research
We test positioning and claims with real audiences to sharpen what you say and how you say it.
Segmentation and targeting
We identify the patient, physician, and payer segments that matter most for your commercial strategy.
Pricing and market access
We model willingness to pay and access barriers so you enter negotiations with real evidence.
Life-cycle management
We find growth opportunities and competitive responses as your brand matures and the market shifts.
Answers to your questions
Find quick answers below or reach out if you need more detail.
How does healogix. approach a new research engagement?
We start by understanding your strategic question, then match it with the right methodology and therapeutic expertise. Every project is built around the specific decision you need to make.
What therapeutic areas does healogix. cover?
Our team has deep experience across a broad range of therapeutic categories, including oncology, rare diseases, neurology, and immunology. We apply that depth to every engagement.
Can healogix. handle global research projects?
Yes. Our network spans key markets worldwide, allowing us to design and execute studies that capture regional nuances without losing strategic coherence.
What types of research methodologies do you use?
We use a mix of qualitative and quantitative methods — from in-depth interviews and advisory boards to conjoint analysis and segmentation modeling. The method follows the question.
How long does a typical project take?
Timelines depend on scope and complexity. A focused message optimization study might run 4 to 6 weeks, while a full life-cycle assessment can take several months. We'll scope it clearly upfront.
What does healogix. deliver at the end of a project?
Actionable recommendations grounded in evidence. You get a clear report, a debrief with the team, and — when useful — ongoing support to implement the findings.
Still have questions?
Contact our team directly and we'll get back to you within one business day.